Ascendis Asking to Open TransCon PTH Trial for Adults in Japan

Ascendis Asking to Open TransCon PTH Trial for Adults in Japan

294391

Ascendis Asking to Open TransCon PTH Trial for Adults in Japan

Ascendis Pharma is requesting regulatory permission to open a Phase 3 clinical trial in Japan, part of its program to assess TransCon PTH as a hormone replacement therapy for adults with hypoparathyroidism at sites worldwide. Ascendis filed a clinical trial notification (CTN) for what it will call the PaTHway Japan Trial with that country’s Pharmaceuticals and Medical Devices Agency (PDMA). “The CTN filing for TransCon PTH represents another milestone as we continue to lay the groundwork to make…

You must be logged in to read/download the full post.